Skip to main content
Caplight Logo









DoriNano

DoriNano

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://dorinano.com/

Last Round

Accelerator

Jul 7, 2025

Total Funding Raised

$185,000

Company Overview

DoriNano is a biotechnology company that develops customizable three-dimensional nanoparticles for targeted therapeutic delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

DNA origamidrug delivery platformnanoparticle platformcancer vaccinescancer immunotherapytargeted drug deliverynucleic acid deliveryprogrammable therapeuticsDNA nanotechnologydrug nanocarrierspharma partnershipspreclinical biotechhead and neck cancerHNSCC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DoriNano Comparables

Compare DoriNano with similar companies based on industry and business-model similarity.

DoriNano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DNA Nanobots
90%
Code Biotherapeutics
76%
GenLumina
75%

DoriNano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 7, 2025
AcceleratorFeb 25, 2025
GrantFeb 24, 2025
AcceleratorMar 18, 2024
GrantMar 30, 2023
Grant
Jul 13, 2022

DoriNano Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2025

    Received funding from Creative Destruction Lab.

  • Feb 25, 2025

    Received funding from Endless Frontier Labs.

DoriNano Filings

Explore SEC and related filing metadata, where available.

DoriNano filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DoriNano's valuation, stock price, and market status.

Is DoriNano a public or private company?

DoriNano is a private company.

What is the current stock price of DoriNano?

DoriNano is a private company with no public stock price. No recent secondary market data is available.

How much is DoriNano worth (valuation)?

Valuation information for DoriNano is not publicly available.

Can I buy DoriNano stock?

DoriNano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DoriNano's last funding round?

DoriNano's most recent funding round was Accelerator on July 7, 2025.

Who are the main investors in DoriNano?

Key investors in DoriNano include Creative Destruction Lab, Massachusetts Life Sciences Center, Harvard Business School, Nucleate, Endless Frontier Labs.

Will DoriNano IPO soon?

No public IPO plans have been announced for DoriNano.

How can I track DoriNano secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DoriNano's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Year FoundedN/A
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?